博济医药

300404 SZSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

3.7B ($537.4M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

742.0M

Net Income

30.7M

Gross Margin

N/A

Op. Margin

2.5%

Net Margin

4.1%

ROE

3.1%

ROA

2.1%

D/E

0.45

Dividend Yield

N/A

EPS

0.08

Current Ratio

1.96

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 博济医药

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.

Ticker	300404
Exchange	SZSE
Sector	证监会行业分类
Industry	M73研究和试验发展